Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 360

1.

Cilazapril and dietary gamma-linolenic acid prevent the deficit in sciatic nerve conduction velocity in the streptozotocin diabetic rat.

Burnard SL, McMurchie EJ, Leifert WR, Patten GS, Muggli R, Raederstorff D, Head RJ.

J Diabetes Complications. 1998 Mar-Apr;12(2):65-73.

PMID:
9559483
2.

Prevention of nerve conduction deficit in diabetic rats by polyunsaturated fatty acids.

Head RJ, McLennan PL, Raederstorff D, Muggli R, Burnard SL, McMurchie EJ.

Am J Clin Nutr. 2000 Jan;71(1 Suppl):386S-92S.

3.

Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids.

Cameron NE, Cotter MA, Horrobin DH, Tritschler HJ.

Diabetologia. 1998 Apr;41(4):390-9.

PMID:
9562342
5.

A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy.

Hounsom L, Horrobin DF, Tritschler H, Corder R, Tomlinson DR.

Diabetologia. 1998 Jul;41(7):839-43.

PMID:
9686927
8.

Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes.

Lowitt S, Malone JI, Salem AF, Korthals J, Benford S.

Metabolism. 1995 May;44(5):677-80.

PMID:
7752919
10.

Essential fatty acids prevent slowed nerve conduction in streptozotocin diabetic rats.

Julu PO.

J Diabet Complications. 1988 Oct-Dec;2(4):185-8.

PMID:
2853165
11.

Alterations of Na,K-ATPase isoenzymes in the rat diabetic neuropathy: protective effect of dietary supplementation with n-3 fatty acids.

Gerbi A, Maixent JM, Barbey O, Jamme I, Pierlovisi M, Coste T, Pieroni G, Nouvelot A, Vague P, Raccah D.

J Neurochem. 1998 Aug;71(2):732-40.

12.

Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.

Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K, et al.

Diabetes Res Clin Pract. 1995 Feb;27(2):107-17.

PMID:
7607048
13.
14.

Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation.

Yorek MA, Wiese TJ, Davidson EP, Dunlap JA, Stefani MR, Conner CE, Lattimer SA, Kamijo M, Greene DA, Sima AA.

Diabetes. 1993 Oct;42(10):1401-6.

PMID:
8397126
15.
16.

Beneficial effects of gamma linolenic acid supplementation on nerve conduction velocity, Na+, K+ ATPase activity, and membrane fatty acid composition in sciatic nerve of diabetic rats.

Coste T, Pierlovisi M, Leonardi J, Dufayet D, Gerbi A, Lafont H, Vague P, Raccah D.

J Nutr Biochem. 1999 Jul;10(7):411-20.

PMID:
15539317
18.

Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy.

Coste TC, Gerbi A, Vague P, Pieroni G, Raccah D.

Diabetes. 2003 Oct;52(10):2578-85.

19.

Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats.

Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K, Naruse K, Nakashima W, et al.

Prostaglandins. 1995 Jun;49(6):339-49.

PMID:
7480803

Supplemental Content

Support Center